Jakob Stilling
Jakob Stilling (1842–1915) was a prominent German ophthalmologist known for his significant contributions to the field of ophthalmology. He is particularly recognized for his work on the diagnosis and treatment of various eye diseases and conditions.
Early Life and Education[edit | edit source]
Jakob Stilling was born on September 22, 1842, in Kassel, Germany. He pursued his medical studies at several universities, including the University of Marburg, the University of Berlin, and the University of Würzburg. Stilling completed his medical degree in 1865.
Career[edit | edit source]
After completing his education, Stilling worked as an assistant to renowned ophthalmologists such as Albrecht von Graefe and Julius Hirschberg. He later became a professor of ophthalmology at the University of Strasbourg, where he made significant advancements in the field.
Contributions to Ophthalmology[edit | edit source]
Stilling is best known for his research on the visual system and the development of diagnostic techniques for eye diseases. He introduced the use of fluorescein in ophthalmology, which became a crucial tool for diagnosing retinal and choroidal conditions. Stilling's work laid the foundation for modern fluorescein angiography.
Stilling's Disease[edit | edit source]
One of Stilling's notable contributions is the identification and description of a condition known as Stilling's disease, a rare congenital disorder affecting the eyes.
Publications[edit | edit source]
Jakob Stilling authored numerous articles and books on ophthalmology, contributing extensively to the medical literature of his time. His works include detailed studies on the anatomy and physiology of the eye, as well as innovative diagnostic and therapeutic techniques.
Legacy[edit | edit source]
Stilling's pioneering work in ophthalmology has had a lasting impact on the field. His contributions to the understanding and treatment of eye diseases continue to influence modern ophthalmic practices.
Related Pages[edit | edit source]
- Ophthalmology
- Albrecht von Graefe
- Fluorescein angiography
- University of Strasbourg
- Stilling's disease
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD